Homology Medicines Inc. (FIXX)
NASDAQ: FIXX
· Real-Time Price · USD
0.93
0.00 (0.26%)
At close: Mar 25, 2024, 9:00 PM
Homology Medicines Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 54.83M | 65.48M | 77.97M | 89.08M | 115.51M | 39.27M | 29.11M | 76.8M | 39.45M | 33.99M | 43.16M | 176.19M | 248.13M | 108.38M | 95.83M | 116.31M | 104.42M |
Short-Term Investments | n/a | n/a | n/a | n/a | 19.8M | 43.39M | 74.19M | 50.27M | 110.57M | 141.04M | 157.91M | 49.34M | 8M | 47.49M | 91.72M | 96.98M | 84.23M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | 13.96M | 17.32M | 23.04M | 25.81M | 27.13M | 29.3M | 30.64M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 1.22M | 3.62M | 3.36M | 3.29M | 6.47M | n/a | n/a | -38M | -44.3M | -47.45M | -49.45M | -46.17M | 276K | 1.95M | 1.27M | 1.27M | 1.27M |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 3.49M | 3.15M | 3.91M | 4.82M | 2.73M | 1.26M | 3.34M | 4.26M | 3.56M | 5.99M | 12.13M | 12.92M | 6.32M | 36.04M | 4.27M | 4.64M | 3M |
Total Current Assets | 58.32M | 68.63M | 81.88M | 93.9M | 138.04M | 83.91M | 106.64M | 131.34M | 153.58M | 181.01M | 213.2M | 238.44M | 262.45M | 191.91M | 191.82M | 217.94M | 191.65M |
Property-Plant & Equipment | 6.58M | 6.82M | 7.09M | 7.36M | 7.82M | 650K | 19.47M | 20.68M | 21.26M | 21.64M | 22.32M | 16.87M | 17.59M | 17.86M | 37.73M | 39.71M | 41.77M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 7.79M | 10.44M | 10.46M | 10.64M | 14.29M | 222.21M | 33.43M | 38M | 44.3M | 47.45M | 49.45M | 46.17M | 48.51M | 19.81M | 39M | 40.98M | 43.05M |
Total Assets | 66.12M | 79.07M | 92.33M | 104.54M | 152.33M | 306.12M | 140.06M | 169.34M | 197.88M | 228.47M | 262.65M | 284.61M | 310.96M | 211.72M | 230.82M | 258.92M | 234.7M |
Account Payables | 910K | 2.71M | 2.99M | 1.26M | 4.96M | 3.23M | 7.8M | 3.39M | 3.63M | 1.14M | 4.83M | 3.76M | 9.88M | 2.37M | 3.52M | 5.7M | 4.88M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 354K | 1.16M | 1.96M | 2.76M | 3.21M | 3.21M | 3.21M | 4.01M | 5.18M |
Short-Term Debt | 6.23M | 4.66M | 3.1M | 1.53M | 3.09M | 1.32M | 1.78M | 1.7M | 1.63M | 1.56M | 1.49M | 410K | 435K | 246K | 1.96M | 2.14M | 2.32M |
Other Current Liabilities | 5.31M | 9.92M | 13.37M | 12.85M | 24.91M | 7.02M | 15.71M | 17.84M | 12.89M | 18.71M | 16.97M | 13.8M | 7.27M | 11.41M | 10.02M | 7.69M | 5.42M |
Total Current Liabilities | 11.53M | 14.58M | 16.46M | 14.38M | 32.95M | 11.57M | 25.29M | 22.94M | 18.51M | 22.58M | 25.25M | 20.73M | 20.8M | 17.23M | 18.7M | 19.53M | 17.81M |
Long-Term Debt | 5.3M | 5.47M | 5.64M | 5.79M | 6.1M | n/a | 26.56M | 27.02M | 27.48M | 27.92M | 28.34M | 23.59M | 23.55M | 23.69M | 11.58M | 12.05M | 12.5M |
Other Long-Term Liabilities | 61.52M | 63.04M | 64.56M | 66.07M | 64.51M | -221.56M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 66.82M | 68.51M | 70.19M | 71.86M | 70.61M | 221.56M | 26.56M | 27.02M | 27.48M | 27.92M | 28.34M | 23.59M | 23.9M | 24.84M | 13.54M | 14.81M | 16.06M |
Total Liabilities | 78.35M | 83.08M | 86.66M | 86.25M | 103.56M | 233.13M | 51.85M | 49.96M | 45.98M | 50.49M | 53.59M | 44.32M | 44.7M | 42.07M | 32.24M | 34.34M | 33.87M |
Total Debt | 11.52M | 10.13M | 8.73M | 7.33M | 9.19M | 1.32M | 28.34M | 28.72M | 29.1M | 29.48M | 29.83M | 24M | 23.98M | 23.93M | 13.54M | 14.19M | 14.82M |
Common Stock | 2K | 2K | 2K | 2K | 2K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 6K | 5K |
Retained Earnings | -255.33M | -245.84M | -234.81M | -220.63M | -186.05M | -542.1M | -525.98M | -493.02M | -457.98M | -429.14M | -394.84M | -361.12M | -332.03M | -424.13M | -390.55M | -359.94M | -329.44M |
Comprehensive Income | n/a | n/a | n/a | -1K | -5K | -5K | -36K | -88K | -182K | -404K | -457K | -41K | n/a | -7K | -5K | 2K | -23K |
Shareholders Equity | -12.23M | -4.01M | 5.67M | 18.3M | 48.77M | 72.99M | 88.21M | 119.38M | 151.9M | 177.98M | 209.06M | 240.29M | 266.25M | 169.65M | 198.57M | 224.58M | 200.83M |
Total Investments | n/a | n/a | n/a | n/a | 19.8M | 43.39M | 74.19M | 50.27M | 110.57M | 166.85M | 185.04M | 78.63M | 38.64M | 47.49M | 91.72M | 96.98M | 84.23M |